Human Immunodeficiency Virus Collection (#5)

HIV virus particle, artwork
HIV virus particle, computer artwork. Each particle (virion) consists of RNA (ribonucleic acid) contained within a capsid and an envelope covered in glycoprotein spikes

HIV virus particles, artwork
HIV virus particles, computer artwork. Each particle (virion) consists of RNA (ribonucleic acid) contained within a capsid and an envelope covered in glycoprotein spikes

Worldwide AIDS epidemic, artwork
Worldwide AIDS epidemic. Conceptual computer artwork of the Earth in the shape of the AIDS (acquired immune deficiency syndrome) virus

Cell infected with HIV, electronic image
Experts of the Ivanovsky Virusology Institute [USSR Academy of Medical Sciences] have made this electronic image of a cell infected with the AIDS virus

HIV replication cycle, diagram
HIV replication cycle. Diagram and magnified views showing the retroviral process by which the human immunodeficiency virus (HIV) replicates

HIV reverse transcriptase enzyme
Artwork of a molecular model of the HIV-1 virus reverse transcriptase enzyme. This enzyme is a protein from the human immunodeficiency virus (HIV) that causes AIDS

HIV particles exiting a cell, artwork
HIV particles exiting a cell. Artwork of HIV (human immunodeficiency virus) particles exiting a T-lymphocyte (white blood cell). HIV causes AIDS (acquired immune deficiency syndrome)

Cell infected with HIV, SEM
Cell infected with HIV. Coloured scanning electron micrograph (SEM) of HIV particles (yellow) budding from the membrane of a host cell (red)

Abacavir AIDS drug molecule. Computer model of a molecule of the AIDS (acquired immune deficiency syndrome) drug abacavir

Reverse transcriptase enzyme from HIV, molecular model. This enzyme is from the human immunodeficiency virus (HIV) that causes AIDS

HIV drug molecule
Tenofovir AIDS drug molecule. Computer model of a molecule of the AIDS (acquired immune deficiency syndrome) drug tenofovir

Ritonavir HIV drug molecule
Ritonavir HIV drug, molecular model. Ritonavir is an antiretroviral drug used to treat HIV (human immunodeficiency virus) infection and AIDS (acquired immune deficiency syndrome) symptoms

Emtricitabine AIDS drug molecule. Computer model of a molecule of the AIDS (acquired immune deficiency syndrome) drug emtricitabine (marketed as Emtriva)

Raltegravir HIV drug molecule
Raltegravir HIV drug, molecular model. Raltegravir (marketed as Isentress) belongs to the integrase inhibitor class of drugs used to treat human immunodeficiency virus (HIV) infections

HIV antibody therapy. Molecular model of the interaction of the HIV surface protein gp120 (green, lower right) as it interacts with a human white blood cell surface protein (CD4, blue)

Amprenavir drug molecule
Amprenavir. Computer model of a molecule of the drug amprenavir. It is also known as VX-478, and is sold under the brand name Agenerase

HIV enzyme being affected by a drug. Molecular model of HIVs reverse transcriptase enzyme as it interacts with a drug (not seen)

For sale as Licensed Images

Choose your image, Select your licence and Download the media

"HIV: Unveiling the Silent Intruder" In a world filled with microscopic battles, the HIV particle emerges as a formidable foe. Its deceptive simplicity belies its destructive power, as it infiltrates human cells and hijacks their machinery. The HIV reverse transcription enzyme cunningly converts its genetic material into DNA, seamlessly integrating itself into our very essence. Through the lens of science, we witness a false-colored TEM image capturing the AIDS virus lurking within a T-cell—a chilling reminder of the relentless assault on our immune system. As if mocking our defenses, AIDS viruses bud from infected cells in another TEM snapshot—an eerie dance of life and death. Amidst this medical turmoil, actor Douglas Lambert bravely faces his diagnosis at St Stephens Hospital. His journey becomes an emblematic representation of countless lives affected by this devastating disease. In North London, Doug's home transforms into both sanctuary and battleground as he valiantly fights against AIDS' merciless grip. The 19th of January marks an important milestone—the opening day for Middlesex Hospital's Broderip AIDS ward—a beacon of hope amidst despair. This dedicated space becomes a haven for those battling against this insidious virus; where compassion meets expertise to provide solace in times of anguish. Time moves forward relentlessly but not without leaving indelible imprints on humanity's fight against HIV/AIDS. On October 31st, 1986—on that fateful Halloween night—Doug succumbs to his battle with AIDS; yet his legacy endures through awareness and advocacy efforts that continue to shape society. A year later, December 16th witnesses another chapter unfold at Middlesex Hospital—the Broderip AIDS ward stands resolute in its mission to care for those afflicted by this epidemic scourge. It serves as a testament to resilience and determination in combating an adversary that knows no boundaries.